JPM vs RVSB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
RVSB presents as a classic value play, trading significantly below its Graham Number ($6.41) and Intrinsic Value ($6.16) with a Price-to-Book ratio of 0.69. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, which is corroborated by a very low ROE of 3.01% and ROA of 0.32%. While the company shows positive YoY revenue and earnings growth, the bearish technical trend and poor asset utilization suggest a lack of immediate momentum. The stock is fundamentally undervalued, but the lack of profitability efficiency prevents a bullish rating.
Compare Another Pair
Related Comparisons
JPM vs RVSB: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Riverview Bancorp, Inc. (RVSB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.